1. Home
  2. GPMT vs CGTX Comparison

GPMT vs CGTX Comparison

Compare GPMT & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • CGTX
  • Stock Information
  • Founded
  • GPMT 2015
  • CGTX 2007
  • Country
  • GPMT United States
  • CGTX United States
  • Employees
  • GPMT N/A
  • CGTX N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPMT Real Estate
  • CGTX Health Care
  • Exchange
  • GPMT Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • GPMT 122.0M
  • CGTX 126.2M
  • IPO Year
  • GPMT 2017
  • CGTX 2021
  • Fundamental
  • Price
  • GPMT $2.75
  • CGTX $1.70
  • Analyst Decision
  • GPMT Buy
  • CGTX Strong Buy
  • Analyst Count
  • GPMT 3
  • CGTX 3
  • Target Price
  • GPMT $3.13
  • CGTX $2.83
  • AVG Volume (30 Days)
  • GPMT 204.3K
  • CGTX 3.3M
  • Earning Date
  • GPMT 11-05-2025
  • CGTX 11-12-2025
  • Dividend Yield
  • GPMT 7.29%
  • CGTX N/A
  • EPS Growth
  • GPMT N/A
  • CGTX N/A
  • EPS
  • GPMT N/A
  • CGTX N/A
  • Revenue
  • GPMT N/A
  • CGTX N/A
  • Revenue This Year
  • GPMT N/A
  • CGTX N/A
  • Revenue Next Year
  • GPMT $26.51
  • CGTX N/A
  • P/E Ratio
  • GPMT N/A
  • CGTX N/A
  • Revenue Growth
  • GPMT N/A
  • CGTX N/A
  • 52 Week Low
  • GPMT $1.61
  • CGTX $0.22
  • 52 Week High
  • GPMT $3.66
  • CGTX $3.83
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 37.65
  • CGTX 52.47
  • Support Level
  • GPMT $2.93
  • CGTX $1.29
  • Resistance Level
  • GPMT $3.03
  • CGTX $1.61
  • Average True Range (ATR)
  • GPMT 0.08
  • CGTX 0.14
  • MACD
  • GPMT -0.04
  • CGTX -0.01
  • Stochastic Oscillator
  • GPMT 0.03
  • CGTX 93.62

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: